3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Classical hematology
1
Conditions
Thrombocytopenia
1
Recurrence
1
Ovarian Neoplasms
1
Interventions
olaparib
5
stinging nettle lectin
1
peppermint oil
1
niraparib
1
liposomal doxorubicin
1
ferrous fumarate
1
apixaban
1
angiotensin I (1-7)
1
Tretinoin
1
Trabectedin
1
Surveys and Questionnaires
1
Rivaroxaban
1
Pharmacokinetics
1
Heparin, Low-Molecular-Weight
1
Genetic Counseling
1
Gemcitabine
1
Ferric Oxide, Saccharated
1
Epoetin Alfa
1
Demography
1
Data Collection
1
Darbepoetin alfa
1
Counseling
1
Cognitive Behavioral Therapy
1
Carboplatin
1
Aspirin
1
Anticoagulants
1
ALT-836
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Ovarian Neoplasms
×
Pharmacokinetics
×
Classical hematology
×
Clear all
NCT04861181
2025-05-22
NIRAPK
Hospices Civils de Lyon
Phase 4
Terminated
12 enrolled